Exton, Pennsylvania (PA) Pharmaceutical Preparations Companies

Featured companies
Elixeon Pharmaceuticals Inc
717 Constitution Drive
Exton PA 19341
(610) 458-5543
Fibrocell Science Inc
405 Eagleview Boulevard
Exton PA 19341
(484) 713-6000
Frontage Laboratories
75 East Uwchlan Avenue
Exton PA 19341
(484) 879-1966
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Frontage Laboratories Inc
700 Pennsylvania Drive
Exton PA 19341
(610) 232-0100
Glaxosmithkline LLC
812 Springdale Drive
Exton PA 19341
(610) 363-2579
Johnson & Johnson Pharmaceutical Research & Development L L C
665 Stockton Drive # 104
Exton PA 19341
(610) 458-2192
Marillion Pharmaceuticals Inc
102 Pickering Way
Exton PA 19341
Pharmaceutical Research Co Inc
602 Jeffers Circle # 110
Exton PA 19341
Pharmaxis Inc
1 East Uwchlan Avenue # 405
Exton PA 19341
(610) 363-5120

Pharmaxis Inc is a privately held company in Exton, PA and is a Unknown business.
Procognia Ltd
760 Constitution Drive
Exton PA 19341
(610) 321-2520
Transsig, Inc.
665 Stockton Drive
Exton PA 19341
Viro Pharma Inc
730 Stockton Drive
Exton PA 19341
(610) 458-7300
Abbott Laboratories
403 Gordon Drive
Exton PA 19341
(610) 280-0130
Whereorg has 13 results under Pharmaceutical Preparations Companies in Exton, PA.

Other locations for category Pharmaceutical Preparations


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020